1991
DOI: 10.1021/bi00102a022
|View full text |Cite
|
Sign up to set email alerts
|

Human serum contains a novel .beta.1,6-N-acetylglucosaminyltransferase activity that is involved in midchain branching of oligo(N-acetyllactosaminoglycans)

Abstract: Incubation of UDP-GlcNAc and radiolabeled GlcNAc beta 1-3Gal beta 1-4GlcNAc beta 1-3Gal beta 1-4GlcNAc (1) with human serum resulted in the formation of the branched hexasaccharide GlcNAc beta 1-3Gal beta 1-4GlcNAc beta 1-3(GlcNAc beta 1-6)Gal beta 1-4GlcNAc (2) in yields of up to 22.2%. The novel reaction represents midchain branching of the linear acceptor; the previously known branching reactions of oligo-(N-acetyllactosaminoglycans) involve the nonreducing end of the growing saccharide chains. The structur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
40
0

Year Published

1996
1996
2001
2001

Publication Types

Select...
3
3
2

Relationship

4
4

Authors

Journals

citations
Cited by 36 publications
(40 citation statements)
references
References 35 publications
0
40
0
Order By: Relevance
“…Glycans 1, 2, and 3 were synthesized essentially as described previously (15,17,19). Gal␤1-4GlcNAc␤1-3Gal␤1-4Glc-PA (lacto-N-neotetraose-PA), Gal␤1-3GlcNAc␤1-3Gal␤1-4Glc-PA (lacto-N-tetraose-PA), and Gal␤1-3GlcNAc␤1-3(Gal␤1-4GlcNAc␤1-6)Gal␤1-4Glc-PA (lacto-Nhexaose-PA) were prepared by pyridylamination of lacto-N-neotetraose, lacto-N-tetraose, and lacto-N-hexaose using the commercial pyridylamination apparatus Glyco TAG (Takara, Shiga, Japan), respectively.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Glycans 1, 2, and 3 were synthesized essentially as described previously (15,17,19). Gal␤1-4GlcNAc␤1-3Gal␤1-4Glc-PA (lacto-N-neotetraose-PA), Gal␤1-3GlcNAc␤1-3Gal␤1-4Glc-PA (lacto-N-tetraose-PA), and Gal␤1-3GlcNAc␤1-3(Gal␤1-4GlcNAc␤1-6)Gal␤1-4Glc-PA (lacto-Nhexaose-PA) were prepared by pyridylamination of lacto-N-neotetraose, lacto-N-tetraose, and lacto-N-hexaose using the commercial pyridylamination apparatus Glyco TAG (Takara, Shiga, Japan), respectively.…”
Section: Methodsmentioning
confidence: 99%
“…We refer to this enzyme activity as dIGnT6 to emphasize the distal site of its action (15,16). The second type of the enzyme activity acts at the midchain positions of the (completed or growing) poly-N-acetyllactosamine chains, converting Gal␤1-4GlcNAc␤1-3Gal␤1-4GlcNAc␤1-R to Gal␤1-4GlcNAc␤1-3(GlcNAc␤1-6)Gal␤1-4GlcNAc␤1-R (13,(15)(16)(17). Accordingly, we refer to this enzyme activity as cIGnT6.…”
mentioning
confidence: 99%
“…Briefly, GlcNAcß 1-3'LacNAcß 1-3'LacNAc [8], was al,3-fucosylated partially by using al,3/4 fucosyltransferase(s) of human milk [9]. The fraction of monofucosylated products was isolated by paper chromatography and the hexasaccharide GlcNAcßl-3'(Fucal-3)LacNAcßl-3'LacNAc was isolated from this fraction by WGA-agarose chromatography (Niemelä et al, loe.…”
Section: Synthesis Of the Heptasaccharidementioning
confidence: 99%
“…Degradative Experiments-Digestions with endo-␤-galactosidase from Bacteroides fragilis (EC 3.2.1.103) (Boehringer Mannheim) were performed according to Leppä nen et al (9); parallel control reactions cleaved over 90% of radiolabeled GlcNAc␤1-3Gal␤1-4GlcNAc.…”
Section: Methodsmentioning
confidence: 99%
“…The "distally acting" dIGnT6 transfers a GlcNAc unit in the ␤1,6 linkage to the penultimate galactose residue at the growing end of the linear polylactosamine chain (Scheme 1) (2)(3)(4)(5)(6)(7)(8). By contrast, the "centrally acting" cIGnT6 transfers a GlcNAc residue in the ␤1,6 linkage to midchain galactose units of preformed as well as growing linear chains (3,9,10). The dIGnT6 reactions proceed only with acceptor chains bearing distal GlcNAc residues, whereas the cIGnT6 works with polylactosamine backbones carrying either a galactose or a GlcNAc residue at the distal position.…”
mentioning
confidence: 99%